$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Recombinant monoclonal antibodies 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • C12N-015/00
  • G01N-033/54
  • G01N-033/60
  • G01N-033/76
출원번호 US-0279248 (1981-07-01)
발명자 / 주소
  • Reading Christopher L. (Kingwood TX)
출원인 / 주소
  • The University of Texas System Cancer Center (Houston TX 02)
인용정보 피인용 횟수 : 237  인용 특허 : 16

초록

Antibodies having binding affinity for two desired antigens, hereinafter “recombinant monoclonal antibodies”; recombinant monoclonal antibodies produced by a quadroma cell or a trioma cell; and methods for producing recombinant monoclonal antibodies by means of a quadroma cell or a trioma cell, wher

대표청구항

An antibody produced by a quadroma cell, wherein said antibody has specific binding affinity for two desired antigens and wherein said quadroma cell comprises the fusion product of: (a) a hyridoma cell which produces an antibody having specific binding affinity to one desired antigen, and (b) a hybr

이 특허에 인용된 특허 (16)

  1. Neville ; Jr. David M. (9624 Parkwood Dr. Bethesda MD 20014) Youle Richard J. (9629 Old Spring Rd. Kensington MD 20795), Anti Thy 1.2 monoclonal antibody-ricin hybrid utilized as a tumor suppressant.
  2. Bieber, Charles P.; Howard, Frank D., Anti-human T-lymphocyte monoclonal antibody.
  3. Galfre Giovanni (Cambridge GB2) Milstein Cesar (Cambridge GB2) Wright Bruce W. (Comberton GB2), Antibody production from hybrid cell line.
  4. Neville ; Jr. David M. (Bethesda MD) Youle Richard J. (Kensington MD) Murray Gary J. (Bethesda MD), Chemical modifications of proteins which induce new receptor specificities and therefore elicit new effects in cells.
  5. Kung Patrick C. (Bridgewater NJ) Goldstein Gideon (Short Hills NJ), Complement-fixing monoclonal antibody to human T cells, and methods of preparing same.
  6. Gillis Steven (15509 NE. 198th Woodinville WA 98072), Hybridoma antibody which inhibits interleukin 2 activity.
  7. David Gary S. (La Jolla CA) Greene Howard E. (Carlsbad CA), Immunometric assays using monoclonal antibodies.
  8. Hansen W. Peter (Middleboro MA) Hoffman Robert A. (Mansfield MA), Method and apparatus for automated identification and enumeration of specified blood cell subclasses.
  9. Koprowski Hilary (Wynnewood PA) Gerhard Walter U. (Philadelphia PA) Croce Carlo M. (Philadelphia PA), Method of producing antibodies.
  10. Koprowski Hilary (Wynnewood PA) Croce Carlo M. (Philadelphia PA), Method of producing tumor antibodies.
  11. Koprowski Hilary (Wynnewood PA) Mitchell Kenneth F. (Unionville PA) Steplewski Zenon (Strafford PA), Monocolonal hybridoma antibody specific for high molecular weight carcinoembryonic antigen.
  12. Wands Jack R. (Waban MA) Zurawski ; Jr. Vincent R. (West Chester PA), Process for producing antibodies to hepatitis virus and cell lines therefor.
  13. Remington Jack S. (Palo Alto CA) Araujo Fausto G. (Palo Alto CA), Sandwich immunoassay and compositions for use therein.
  14. Goldenberg Milton D. (11837 Gainsborough Rd. Potomac MD 20854), Tumor localization and therapy with labeled anti-CEA antibody.
  15. Goldenberg Milton D. (11837 Gainsborough Rd. Potomac MD 20854), Tumor localization and therapy with labeled antibodies specific to intracellular tumor-associated markers.
  16. Goldenberg Milton D. (11837 Gainsborough Rd. Potomac MD 20854), Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers.

이 특허를 인용한 특허 (237)

  1. Zauderer, Maurice; Evans, Elizabeth E., Anti-C35 antibody combination therapies and methods.
  2. Reyes, Christopher L.; Chu, Peter; Tan, Xiangyang; Yang, Weixing; Graff, Christilyn, Anti-GPR49 monoclonal antibodies.
  3. Freeman, Gordon J.; Ahmed, Rafi; Jones, Timothy D.; Carr, Francis J.; Gregson, James P., Anti-PD-L1 antibodies and uses therefor.
  4. Lallatin, Nathaniel; O'Neill, Kim L., Anti-cancer activity of an anti-thymidine kinase monoclonal antibody.
  5. Aaron,Wade; Austin,Richard J.; Hart,Cynthia L.; Hoey,Timothy C.; Kassner,Paul D.; Piper,Derek E.; Slavin,Anthony J., Anti-galanin antibodies and uses thereof.
  6. Williamson, Robert Anthony; Wadia, Jehangir; Pascual, Gabriel; Keogh, Elissa, Anti-human Respiratory Syncytial Virus (RSV) antibodies and methods of use.
  7. Williamson, Robert Anthony; Wadia, Jehangir; Pascual, Gabriel; Keogh, Elissa, Anti-human respiratory syncytial virus (RSV) antibodies and methods of use.
  8. Williamson, Robert Anthony; Wadia, Jehangir; Pascual, Gabriel; Keogh, Elissa, Anti-human respiratory syncytial virus (RSV) antibodies and methods of use.
  9. Suiko Masahito,JPX, Anti-sulfated tyrosine antibody specific for sulfated tyrosine, process for producing the same, and hybridoma capable of.
  10. Lallatin,Nathaniel; O'Neill,Kim L., Anti-viral activity of an anti-thymidine kinase monoclonal antibody.
  11. McAuliffe, Josephine; Palmer-Hill, Frances; Zhu, Qing; Suzich, JoAnn, Antibodies against and methods for producing vaccines for respiratory syncytial virus.
  12. McAuliffe, Josephine; Palmer-Hill, Frances; Zhu, Qing; Suzich, Joann, Antibodies against and methods for producing vaccines for respiratory syncytial virus.
  13. Williamson, Robert Anthony; Wadia, Jehangir; Pascual, Gabriel; Keogh, Elissa, Antibodies against human respiratory syncytial virus (RSV) and methods of use.
  14. Williamson, Robert Anthony; Wadia, Jehangir; Pascual, Gabriel; Keogh, Elissa, Antibodies against human respiratory syncytial virus (RSV) and methods of use.
  15. Rosinski-Chupin Isabelle,FRX ; Tronik Diana,FRX ; Rougeon Francois,FRX ; Seidah Nabil,CAX, Antibodies directed against peptides derived from the SMR1 polypeptide.
  16. Hayashi Akio (Osaka JPX) Hiramatsu Makoto (Osaka JPX) Hamanaka Nobuyuki (Osaka JPX), Antibodies for mevalonic acid and methods for immunological determination of mevalonic acid by using them.
  17. Hellstrom Ingegerd ; Hellstrom Karl Erik ; Bruce Kim Folger ; Schreiber George J. ; Siegall Clay ; McAndrew Stephen, Antibodies reactive with human carcinomas.
  18. Reyes, Christopher L.; Smith, Kristen M.; Chu, Peter; Campbell, Lioudmila A.; Ailor, Eric, Antibodies that bind LGR4, their use in inhibiting neoplastic cells and in treating tumors.
  19. Keler, Tibor; He, Lizhen; Ramakrishna, Venky; Vitale, Laura A., Antibodies that bind human dendritic and epithelial cell 205 (DEC-205).
  20. Keler, Tibor; He, Lizhen; Ramakrishna, Venky; Vitale, Laura A., Antibodies that bind human dendritic and epithelial cell 205 (DEC-205).
  21. Keler, Tibor; He, Lizhen; Ramakrishna, Venky; Vitale, Laura A., Antibodies that bind human dendritic and epithelial cell 205 (DEC-205).
  22. Keler, Tibor; He, Lizhen; Ramakrishna, Venky; Vitale, Laura A., Antibodies that bind human dendritic and epithelial cell 205 (DEC-205).
  23. Reed Guy L. ; Haber Edgar ; Matsueda Gary R., Antibodies that bind to .alpha.2-antiplasmin crosslinked to fibrin which do not inhibit plasma .alpha.2-antiplasmin.
  24. Reed Guy L. ; Haber Edgar ; Matsueda Gary R., Antibodies that bind to .alpha.2-antiplasmin crosslinked to fibrin which do not inhibit plasma .alpha.2-antiplasmin.
  25. Zauderer, Maurice; Evans, Elizabeth E., Antibodies that bind to the C35 polypeptide.
  26. Zauderer, Maurice; Evans, Elizabeth E., Antibodies that bind to the C35 polypeptide.
  27. Reed, Guy L.; Haber, Edgar; Matsueda, Gary R., Antibodies that bind to α2-antiplasmin crosslinked to fibrin which do not inhibit plasma α2-antiplasmin.
  28. Boyle,William J.; Martin,Francis H.; Corvalan,Jose R.; Davis,C. Geoffrey, Antibodies to OPGL.
  29. Deeley Roger G.,CAX ; Cole Susan P. C.,CAX, Antibodies to a multidrug resistance protein.
  30. Ni,Jian; Rosen,Craig A.; Gentz,Reiner L., Antibodies to human tumor necrosis factor receptor-like 2.
  31. Elenbaas,Brian; Jarpe,Matthew B; Miklasz,Steven D.; Fawell,Stephen E., Antibodies to the human prolactin receptor.
  32. Terry Thomas CA; Peter Lansdorp CA, Antibody compositions for preparing enriched cell preparations.
  33. Thomas Terry,CAX ; Lansdorp Peter,CAX, Antibody compositions for preparing enriched cell preparations.
  34. Terry Thomas CA; Peter Lansdorp CA, Antibody compositions for preparing enriched dendritic cell preparations.
  35. Hellstrom Ingegerg ; Hellstrom Karl Erik ; Bruce Kim Folger ; Schreiber George J., Antibody conjugates reactive with human carcinomas.
  36. Lerchen, Hans-Georg; Wittrock, Sven; Griebenow, Nils; Stelte-Ludwig, Beatrix; Sommer, Anette; Berndt, Sandra; Mahlert, Christoph; Lobell, Mario; Terjung, Carsten; Greven, Simone; Cancho Grande, Yolanda, Antibody drug conjugates (ADCs) with kinesin spindel protein (KSP).
  37. Kriegler Michael (San Francisco CA) Perez Carl (Berkeley CA), Antibody methods for the treatment of a hormone-mediated disease.
  38. Keler, Tibor; Endres, Michael; He, Lizhen; Ramakrishna, Venky, Antibody vaccine conjugates and uses therefor.
  39. Keler, Tibor; Endres, Michael; He, Lizhen; Ramakrishna, Venky, Antibody vaccine conjugates and uses therefor.
  40. Ebner, Reinhard; Yu, Guo-Liang; Ruben, Steven M.; Ullrich, Stephen; Zhai, Yifan, Apoptosis inducing molecule II and methods of use.
  41. Kriegler Michael (San Francisco CA) Perez Carl (Berkeley CA), Assay method for the detection of 26kd TNF prohormone.
  42. Nichols, Jeremy; Schüle, Birgitt, Assay to determine LRRK2 activity in parkinson's disease.
  43. Nichols, Jeremy; Schüle, Birgitt, Assay to determine LRRK2 activity in parkinson's disease.
  44. Lindhofer, Horst; Kolb, Hans-Jochem; Thierfelder, Stefan, Bi-and trispecific antibodies for the induction of anti-tumor immunity.
  45. Sledziewski Andrzej Z. ; Bell Lillian Anne ; Kindsvogel Wayne R., Biologically active dimerized and multimerized polypeptide fusions.
  46. Yang, Haining; Carbone, Michele; Pass, Harvey I., Biomarker of asbestos exposure and mesothelioma.
  47. Van Wie Bernard J. ; Davis William C. ; Moffett David F. ; Koch Alan R. ; Silber Moris ; Reiken Steven R. ; Sutisna Himawan,IDX, Biosensor for detecting the presence of chosen analytes.
  48. Gunn, III, Lawrence Cary; Iqbal, Muzammil; Spaugh, Brad; Tybor, Frank, Biosensors based on optical probing and sensing.
  49. Igawa, Tomoyuki; Sampei, Zenjiro; Kojima, Tetsuo; Soeda, Tetsuhiro; Muto, Atsushi; Kitazawa, Takehisa; Nishida, Yukiko; Imai, Chifumi; Suzuki, Tsukasa; Yoshihashi, Kazutaka, Bispecific antibodies.
  50. Chen, Yongmei; Ernst, James; Kim, Hok Seon; Sonoda, Junichiro; Spiess, Christoph; Stawicki, Scott; Wu, Yan, Bispecific antibodies binding to beta-klotho and fibroblast growth factor receptor 1.
  51. Ring David ; Shi Tian-Xiang, Bispecific antibodies, methods of production and use thereof.
  52. Ring David ; Shi Tian-Xiang, Bispecific antibodies, methods of production and uses thereof.
  53. Hattori, Kunihiro; Kojima, Tetsuo; Miyazaki, Taro; Soeda, Tetsuhiro, Bispecific antibody substituting for functional proteins.
  54. Long, Michael W.; Mann, Kenneth G., Bone precursor cells: compositions and methods.
  55. Long,Michael W.; Mann,Kenneth G., Bone precursor cells: compositions and methods.
  56. Lancaster, Johnathan; Marchion, Douglas C.; Chen, Dung-Tsa, Cancer platinum resistance detection and sensitization method.
  57. Botstein,David; Goddard,Audrey; Lawrence,David A.; Pennica,Diane; Roy,Margaret Ann; Wood,William I., Cardiotrophin-1 compositions and methods for the treatment of tumor.
  58. Lindahl Tomas,SEX ; Larsson Anders,SEX, Characterization or determination of the amount of blood cells by means of poultry antibodies.
  59. Kriegler Michael (San Francisco CA) Perez Carl (Berkeley CA), Cleavage site blocking antibody to prohormone proteins and uses thereof.
  60. Reed Guy L. ; Harris Linda ; Bajorath Jurgen ; Matsueda Gary ; Hsu Mei-Yin ; Novotny Jiri, Composition and method for enhancing fibrinolysis.
  61. O'Neill, Kim Leslie; Whitehurst, Robert Alan; Evans, Jaden Duss; Sharp, Daniel Williar; Alegre, Melissa Marie, Compositions and methods for cancer management using antibodies binding to nucleotide salvage pathway enzymes and complexes thereof.
  62. Schurpf, Thomas; Mahanthappa, Nagesh K.; Straub, Michelle Marie, Compositions and methods for growth factor modulation.
  63. Schurpf, Thomas; Mahanthappa, Nagesh K.; Straub, Michelle Marie, Compositions and methods for growth factor modulation.
  64. Schurpf, Thomas; Mahanthappa, Nagesh K.; Straub, Michelle Marie, Compositions and methods for growth factor modulation.
  65. Shen, Enyun; Ren, Shiqi, Compositions and methods related to the prevention and treatment of rabies infection.
  66. Nezu, Junichi; Narita, Atsushi; Ishiguro, Takahiro; Sakurai, Mika; Shiraiwa, Hirotake; Hironiwa, Naoka; Igawa, Tomoyuki; Kawai, Yumiko, Cytotoxicity-inducing theraputic agent.
  67. Sledziewski Andrzej Z. ; Bell Lillian Anne ; Kindsvogel Wayne R., DNA constructs encoding ligand-binding fusion proteins.
  68. Dryja,Thaddeus P.; Friend,Stephen, Detection of proteins whose absence is associated with a neoplasm.
  69. Murray,Allen K., Determination of recombinant glycosylated proteins and peptides in biological fluids.
  70. Dryja Thaddeus P. ; Friend Stephen ; Yandell David W., Diagnosis of retinoblastoma.
  71. Petrou, Steven; Berkovic, Samuel Frank; Scheffer, Ingrid Eileen, Diagnostic method for epilepsy.
  72. Mezes Peter S. ; Richard Ruth A. ; Affholter Joseph A. ; Kotite Nicolas J., Dimer and multimer forms of single chain polypeptides.
  73. Mezes Peter S. ; Richard Ruth A. ; Affholter Joseph A. ; Kotite Nicolas J., Dimer and multimer forms of single chain polypeptides.
  74. Sledziewski Andrzej Z. ; Bell Lillian Anne ; Kindsvogel Wayne R., Dimerized polypeptide fusions.
  75. Schlossman Stuart F. (Newton Center MA) Morimoto Chikao (Needham MA), Distinguishing subsets of human cells.
  76. Pandey,Ravindra K.; Dougherty,Thomas J.; Pallenberg,Alexander J., Efficient synthesis of pyropheophorbide a and its derivatives.
  77. Fibi Mathias,DEX ; Stuber Werner,DEX, Erythropoietin (EPO) peptides and antibodies directed against these.
  78. Fibi, Mathias; St?ber, Werner, Erythropoietin (EPO) peptides and antibodies directed against these.
  79. Johnson, Leslie S.; Rainey, Godfrey Jonah Anderson; Gorlatov, Sergey; Lerner, Laura, Fc region-containing polypeptides that exhibit improved effector function due to alterations of the extent of fucosylation, and methods for their use.
  80. Pandey, Ravindra K.; Potter, William R.; Dougherty, Thomas J., Fluorinated photosensitizers related to chlorins and bacteriochlorins for photodynamic therapy.
  81. Charles, Matthew, Formulations of human tissue kallikrein-1 for parenteral delivery and related methods.
  82. Fernandez, Jason E.; Dixon, Daniel A.; Paulson, Andrea, Formulations of single domain antigen binding molecules.
  83. Deshpande,Rajendra V.; Tsai,Mei Mei, Fully human antibody Fab fragments with human interferon-gamma neutralizing activity.
  84. Chan, Vivien W.; Escobedo, Jaime; Garcia, Pablo Dominguez; Hansen, Rhonda; Kaufmann, Joerg; Kennedy, Giulia C.; Lamson, George; Moler, Edward J.; Randazzo, Filippo; Reinhard, Christoph; Sudduth-Klinger, Julie, Gene products differentially expressed in cancerous cells.
  85. Ghaderi, Darius; da Silva, Ana Paula Galvao, Glycan-interacting compounds.
  86. Ghaderi, Darius; da Silva, Ana Paula Galvao, Glycan-interacting compounds.
  87. DeSander, Julie; Behrens, Jeffrey; Lugovskoy, Alexey Alexandrovich, Glycan-interacting compounds and methods of use.
  88. Busfield, Samantha J.; Villeval, Jean-Luc, Glycoprotein VI and uses thereof.
  89. Gill, Davinder Singh; Qian, Ming Diana, Glycoprotein VI and uses thereof.
  90. Gill,Davinder Singh; Qian,Ming Diana, Glycoprotein VI and uses thereof.
  91. Leung Shui-on ; Hansen Hans ; Qu Zhengxing, Glycosylated humanized B-cell specific antibodies.
  92. Harari, Daniel; Yarden, Yosef, Growth factor which acts through ErbB-4 RTK.
  93. Harari,Daniel; Yarden,Yosef, Growth factor which acts through erb b-4 rtk.
  94. Berman,Phillip W.; Fendly,Brian M.; Gregory,Timothy J.; Wurm,Florian M., HIV env antibodies.
  95. Anderson David C. (San Bruno CA) Mathews Antony James (Louisville CO), Hemoglobins as drug delivery agents.
  96. Anderson David C. ; Mathews Antony James, Hemoglobins as drug delivery agents.
  97. W. H. Kerr Anderson ; Philip R. Tempest GB; Frank J. Carr GB; William J. Harris GB; Kathryn Armour GB, High affinity humanized anti-TAG-72 monoclonalantibodies.
  98. Li, Yi, Human G-protein chemokine receptor HSATU68.
  99. Boyle, William J.; Medlock, Eugene; Sullivan, John J.; Elliott, Robin L.; Martin, Frank; Huang, Haichun, Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors.
  100. Boyle, William J.; Medlock, Eugene; Sullivan, John K.; Elliott, Robin L.; Martin, Frank; Huang, Haichun, Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors.
  101. Boyle, William J.; Medlock, Eugene; Sullivan, John K.; Elliott, Robin L.; Martin, Frank; Huang, Haichun, Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors.
  102. Freeman, Gordon J.; Ahmed, Rafi; Jones, Timothy D.; Carr, Francis J.; Gregson, James P., Human anti-PD-1 antibodies and uses therefor.
  103. Freeman, Gordon J.; Ahmed, Rafi; Jones, Timothy D.; Carr, Francis J.; Gregson, James P., Human anti-PD-1, PD-L1, and PD-L2 antibodies and uses therefor.
  104. Tsuji Kouichi,JPX ; Yoshida Yoshihiro,JPX ; Uwano Takashi,JPX, Human lung adenocarcinoma-related monoclonal antibody and immunoassay method which uses the same.
  105. Scannon Patrick J. (Davis CA) Spitler Lynn E. (Tiburon CA) Lee Howard M. (San Francisco CA) Kawahata Russell T. (San Francisco CA) Mischak Ronald P. (Palo Alto CA), Human melanoma specific immunotoxins.
  106. Deo, Yashwant M.; Keler, Tibor; Treml, John, Human monoclonal antibodies to dendritic cells.
  107. Charles, Matthew; Kolodka, Tadeusz; Williams, Mark, Human tissue kallikrein 1 glycosylation isoforms.
  108. Charles, Matthew; Kolodka, Tadeusz; Williams, Mark, Human tissue kallikrein 1 glycosylation isoforms.
  109. Engleman Edgar G. (Atherton CA) Foung Steven K. H. (San Francisco CA) Grumet F. Carl (Stanford CA), Human-murine hybridoma fusion partner.
  110. Reyes, Christopher L.; Chu, Peter; Smith, Kristen M.; Campbell, Lioudmila A.; Shojaei, Farbod; Norton, John Thomas, Humanized antibodies that bind LGR5.
  111. Quertermous Thomas (Nashville TN) Runge Marschall S. (Atlanta GA) Haber Edgar (Salisbury NH), Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production.
  112. Quertermous Thomas ; Runge Marschall Stevens ; Haber Edgar, Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production.
  113. Turtle, Cameron J.; Riddell, Stanley R., Identifcation of CD8+ T cells that are CD161hi and/or IL18Rαhi and have rapid drug efflux capacity.
  114. Turtle, Cameron J.; Riddell, Stanley R., Identification of CD8+ T cells that are CD161hi and/or IL18Rαhi and have rapid drug efflux capacity.
  115. Sahin, Ugur; Tureci, Ozlem; Koslowski, Michael; Usener, Dirk, Identification of tumor-associated antigens for diagnosis and therapy.
  116. Sahin, Ugur; Türeci, Özlem; Koslowski, Michael; Usener, Dirk, Identification of tumor-associated antigens for diagnosis and therapy.
  117. Schoemaker Hubert J. P. (Devon PA) Sun Lee K. (Media PA), Immunoreactive heterochain antibodies.
  118. Goldenberg,Milton D., Intraoperative, intravascular and endoscopic tumor and lesion detection, biopsy and therapy.
  119. Milton David Goldenberg, Intraoperative, intravascular and endoscopic tumor and lesion detection, biopsy and therapy.
  120. Goldenberg Milton David, Intraoperative, intravascular, and endoscopic tumor and lesion detection, biopsy and therapy.
  121. Wylie Dwane E. ; Lopez Osvaldo ; Murray Peter Joseph ; Goebel Peter, Lead binding polypeptides and nucleotides coding therefore.
  122. Haake David A. ; Shang Ellen S., Leptospira membrane proteins.
  123. Haake, David A.; Shang, Ellen S., Leptospira rare outer membrane proteins.
  124. Haake David A., Leptospiral outer membrane protein, LipL46.
  125. Haake David A., Leptospiral outer membranes protein, LipL46.
  126. Sledziewski Andrzej Z. ; Bell Lillian Anne ; Kindsvogel Wayne R., Ligand-binding, dimerized polypeptide fusions.
  127. Lopez Osvaldo ; Wylie Dwane E. ; Wagner Fred W., Mercury binding polypeptides and nucleotides coding therefore.
  128. Johnson David K. (Vernon Hills IL), Metal ion-ligand coordination complexes, antibodies directed thereto, and assays using such antibodies.
  129. Johnson David K. (Vernon Hills IL), Metal ion-ligand coordination complexes, antibodies directed thereto, and assays using such antibodies.
  130. Johnson David K. (Vernon Hills IL), Metal ion-ligand coordination complexes, antibodies directed thereto, and assays using such antibodies.
  131. Bogart Mark (3432 Pershing Ave. San Diego CA 92104), Method for assessing placental dysfunction.
  132. Reiter Robert E. ; Witte Owen N., Method for diagnosing cancer using specific PSCA antibodies.
  133. Belardinelli, Luiz; Grant, Maria B., Method for identifying and using A2B adenosine receptor antagonists to mediate mammalian cell proliferation.
  134. Stevens John K.,CAX ; Dunn James M.,CAX ; Capatos Denis,CAX ; Matthews David E.,CAX, Method for testing for mutations in DNA from a patient sample.
  135. Ranade,Koustubh; Delmonte,Terrye Aigeldinger; Geese,William J., Method of identifying a PPARgamma-agonist compound having a decreased likelihood of inducing dose-dependent peripheral edema.
  136. Igawa, Tomoyuki; Tsunoda, Hiroyuki; Tachibana, Tatsuhiko; Kuramochi, Taichi, Method of modifying isoelectric point of antibody via amino acid substitution in CDR.
  137. Bentires-Alj, Mohamed; Aceto, Nicola; Stadler, Michael, Method of treatment of breast cancers over-expressing the SHP2 signature genes.
  138. Baric, Ralph; Agnihothram, Sudhakar; Yount, Boyd, Methods and compositions for chimeric coronavirus spike proteins.
  139. Bailey, Ryan C.; Luchansky, Matthew S.; Qavi, Abraham J.; Kindt, Jared T., Methods and compositions for enhancing immunoassays.
  140. Keesee Susan K. ; Obar Robert ; Wu Ying-Jye, Methods and compositions for the detection of cervical cancer.
  141. Vinata B. Lokeshwar ; Henry T. Pham, Methods for detection and evaluation of bladder cancer.
  142. Hellstrom Ingegerd ; Hellstrom Karl Erik ; Bruce Kim Folger ; Schreiber George J., Methods for determining the presence of carcinoma using the antigen binding region of monoclonal antibody BR96.
  143. Deeley Roger G.,CAX ; Cole Susan P. C.,CAX, Methods for identifying multidrug resistant tumor cells.
  144. Gregorio Aversa ; Chia-Chun J. Chang ; Benjamin G. Cocks ; Jan E. de Vries, Methods for modulating SLAM-expressing T cells.
  145. Thomas Terry,CAX ; Lansdorp Peter,CAX, Methods for preparing enriched human hematopoietic cell preparations.
  146. Igawa, Tomoyuki; Tsunoda, Hiroyuki, Methods for producing polypeptides by regulating polypeptide association.
  147. Igawa, Tomoyuki; Tsunoda, Hiroyuki, Methods for producing polypeptides by regulating polypeptide association.
  148. Sledziewski Andrzej Z. ; Bell Lillian Anne ; Kindsvogel Wayne R., Methods for producing secreted ligand-binding fusion proteins.
  149. Brown, Paul R.; Tobler, Scott Andreas; Wood, Andrew M.; Boesch, Austin Wayne, Methods for purification of single domain antigen binding molecules.
  150. Keesee Susan K. ; Obar Robert ; Wu Ying-Jye, Methods for the detection of cervical cancer.
  151. Keesee, Susan K.; Obar, Robert; Wu, Ying-Jye, Methods for the detection of cervical cancer.
  152. Reyes, Christopher L.; Chu, Peter; Tan, Xiangyang; Graff, Christilyn; Yang, Weixing, Methods of inhibiting growth of a colon cancer tumor in a subject by administering monoclonal antibodies to G protein-coupled receptor 49 (GPR49).
  153. Reyes, Christopher L.; Chu, Peter; Tan, Xiangyang; Graff, Christilyn; Yang, Weixing, Methods of inhibiting solid tumor growth by administering GPR49 antibodies.
  154. Igawa, Tomoyuki; Tsunoda, Hiroyuki, Methods of modifying antibodies for purification of bispecific antibodies.
  155. Sattler, Martin; Deshpande, Anagha; Griffin, James D., Methods of predicting resistance to JAK inhibitor therapy.
  156. Reyes, Christopher L.; Chu, Peter; Tan, Xiangyang; Yang, Weixing; Graff, Christilyn, Methods of treating cancer by administering anti-GPR49 antibodies.
  157. Chen, Yongmei; Ernst, James; Kim, Hok Seon; Sonoda, Junichiro; Spiess, Christoph; Stawicki, Scott; Wu, Yan, Methods of treatment with bispecific antibodies binding to beta-klotho and fibroblast growth factor receptor 1.
  158. Sledziewski Andrzej Z. (Seattle WA) Bell Lillian A. (Seattle WA) Kindsvogel Wayne R. (Seattle WA), Methods of using biologically active dimerized polypeptide fusions to detect PDGF.
  159. Deo, Yashwant M.; Keler, Tibor; Treml, John; Endres, Michael, Methods of using molecular conjugates comprising monoclonal antibodies to dendritic cells.
  160. Deo, Yashwant M.; Keler, Tibor; Treml, John; Endres, Michael, Molecular conjugates comprising human monoclonal antibodies to dendritic cells.
  161. Ring David ; Shi Tian-Xiang, Monoclonal anti-multiple drug resistance antibody, methods of production and uses thereof.
  162. Meares Claude F. (3310 Trawler Pl. Davis CA 95616) David Gary S. (9477 Poole St. La Jolla CA 92037), Monoclonal antibodies against metal chelates.
  163. Sahin, Ugar; Koslowski, Michael; Tureci, Ozlem, Monoclonal antibodies for treatment of cancer.
  164. Sahin, Ugur; Koslowski, Michael; Tureci, Ozlem, Monoclonal antibodies for treatment of cancer.
  165. Sahin, Ugur; Koslowski, Michael; Türeci, Özlem, Monoclonal antibodies for treatment of cancer.
  166. Sahin, Ugur; Koslowski, Michael; Türeci, Özlem, Monoclonal antibodies for treatment of cancer.
  167. Sahin, Ugur; Tureci, Ozlem; Koslowski, Michael; Mitnacht-Kraus, Rita, Monoclonal antibodies for treatment of cancer.
  168. Sahin, Ugur; Tureci, Ozlem; Koslowski, Michael; Mitnachtkraus, Rita, Monoclonal antibodies for treatment of cancer.
  169. Wagner Fred W. (Walton NE) Wylie Dwane E. (Lincoln NE) Schuster Sheldon M. (Gainesville FL), Monoclonal antibodies specific for metallic cations and method therefor.
  170. Testa Jacqueline E. ; Quigley James P. ; Seandel Marco, Monoclonal antibodies that recognize antigens associated with tumor metastasis.
  171. Deo, Yashwant M.; Keler, Tibor; Treml, John; Endres, Michael, Monoclonal antibodies to dendritic cells.
  172. Lallatin, Nathaniel C., Monoclonal antibodies to human thymidine kinase to treat cancer.
  173. Kuroiwa Katsumasa,JPX ; Katayama Katsuhiro,JPX ; Tomiyama Takahiro,JPX ; Miura Toshihide,JPX ; Nagasawa Takeshi,JPX, Monoclonal antibody to prostate-derived acid phosphatase and method for determination of acid phosphatase using the same.
  174. Hnatowich, Donald J.; Rusckowski, Mary; Liu, Guozheng, Morpholino imaging and therapy.
  175. Pandey, Ravindra K.; Goswami, Lalit; Spernyak, Joseph; Kanter, Peter; Mazurchuk, Richard, Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents.
  176. Brogan,John Bucknam, Multifunctional cross-bridged tetraaza macrocyclic compounds and methods of making and using.
  177. King David John,GBX ; Mountain Andrew,GBX ; Owens Raymond John,GBX ; Yarranton Geoffrey Thomas,GBX, Multivalent antigen-binding proteins.
  178. Mezes Peter S. ; Gourlie Brian B., Multivalent single chain antibodies.
  179. Mezes Peter S. ; Gourlie Brian B., Multivalent single chain antibodies.
  180. Chatterjee,Malaya; Kohler,Heinz; Chatterjee,Sunil K.; Foon,Kenneth A., Murine monoclonal anti-idiotype antibody 3H1 sequences for human carcinoembryonic antigen.
  181. Yelton Dale ; Glaser Scott ; Huse William ; Rosok Mae Joanne, Mutant BR96 antibodies reactive with human carcinomas.
  182. Yelton Dale ; Glaser Scott ; Huse William ; Rosok Mae Joanne, Mutant BR96 antibodies reactive with human carcinomas.
  183. Mulley, John Charles; Harkin, Louise Anne; Dibbens, Leanne Michelle; Phillips, Hilary Anne; Heron, Sarah Elizabeth; Berkovic, Samuel Frank; Scheffer, Ingrid Eileen; Davy, Anne, Mutations in ion channels.
  184. Foung Steven K. H. (San Francisco CA) Blunt Judith A. (Fremont CA) Rabin Linda B. (Alameda CA) Grumet F. Carl (Stanford CA) Engleman Edgar G. (Atherton CA), Non-human primate monoclonal antibodies and methods.
  185. Mulley, John Charles; Harkin, Louise Anne; Dibbens, Leanne Michelle; Wallace, Robyn Heather; Phillips, Hilary Anne; Heron, Sarah Elizabeth; Berkovic, Samuel Frank; Scheffer, Ingrid Eileen, Nucleic acid encoding SCN1A variant.
  186. Chen, Yongmei; Ernst, James; Kim, Hok Seon; Sonoda, Junichiro; Spiess, Christoph; Stawicki, Scott; Wu, Yan, Nucleic acids encoding bispecific antibodies binding to beta-Klotho and fibroblast growth factor receptor 1.
  187. Bailey, Ryan C.; Qavi, Abraham J.; Kindt, Jared T.; Byeon, Ji-Yeon; Luchansky, Matthew S.; McClellan, Melinda S.; Washburn, Adam L.; Owen, Tate; Gleeson, Martin Anthony; Gunn, III, Lawrence C., Optical analyte detection systems and methods of use.
  188. Li, Betty; Jooss, Karin; Korman, Alan J., PD-1 antibodies in combination with a cytokine-secreting cell and methods of use thereof.
  189. Rosinski-Chupin, Isabelle; Tronik, Diana; Rougeon, Fran?ois; Seidah, Nabil, PEPTIDES AND POLYPEPTIDES DERIVED FROM THE SUBMAXILLARY GLAND OF THE RAT CORRESPONDING POLYCLONAL AND MONOCLONAL ANTIBODIES CORRESPONDING HYBRIDOMAS AND USES OF THESE PRODUCTS FOR DIAGNOSIS FOR DETEC.
  190. Li, Betty; Jooss, Karin; Korman, Alan J., PS-1 antibodies in combination with a cytokine-secreting cell and methods of use thereof.
  191. Reiter, Robert E.; Witte, Owen N., PSCA: prostate stem cell antigen and distinguishing androgen receptor negative prostate cancer from benign prostatic hyperplasia.
  192. Reiter, Robert E.; Witte, Owen N., PSCA: prostate stem cell antigen and uses thereof.
  193. Reiter,Robert E.; Witte,Owen N.; Saffran,Douglas C.; Jakobovits,Aya, PSCA: prostate stem cell antigen and uses thereof.
  194. Subramanian Ramaswamy (Frederick MD) Shi Fang (Gaithersburg MD), Polymer affinity system for the delivery of cytotoxic material and other compounds to sites of disease.
  195. Feder,John N.; Nelson,Thomas C.; Chen,Jian; Meegalla,Rupalie; Ramaker,Michael; Cheng,Dong, Polynucleotide encoding a novel acyl coenzyme A, monoacylglycerol acyltransferase-3 (MGAT3), and uses thereof.
  196. Zauderer, Maurice; Evans, Elizabeth E., Polynucleotides encoding antibodies that bind to the C35 polypeptide.
  197. Zauderer, Maurice; Evans, Elizabeth E., Polynucleotides encoding antibodies that bind to the C35 polypeptide.
  198. Peters, Heiko; Balling, Rudolf; Hofler, Heinz; Richter, Thomas, Probe for the early detection of displasias in multilayer tesselated epithelium and for the diagnosis and therapy of carcinomas.
  199. 25770 ; 19900500 ; Ichiura et al., Process for the production of hetero-bispecific antibodies.
  200. Weiner George J. ; Rokhlin Oskar W. ; Cohen Michael B., Prostate cell surface antigen-specific antibodies.
  201. Weiner, George J.; Rokhlin, Oskar W.; Cohen, Michael B., Prostate cell surface antigen-specific antibodies.
  202. Sharma, Sr., Monika S.; Shah, Ambarish; Hammond, Scott, Protein formulation.
  203. Reading Christopher L. (Kingwood TX), Quadroma cells and trioma cells and methods for the production of same.
  204. Buchsbaum Donald J. (Minnetonka MN) Vallera Daniel A. (Minneapolis MN), Radioimmunotoxins.
  205. Adamczyk Maciej ; Chen Yon-Yih ; Walling John A. ; James Bryan D. ; Artrip Sharon G., Reagents and methods for the detection and quantification of testosterone in fluid samples.
  206. Guo, Ailan; Lee, Kimberly; Rikova, Klarisa; Farnsworth, Charles; Moritz, Albrecht; Li, Yu; Polakiewicz, Robert, Reagents for the detection of protein phosphorylation in EGFR-signaling pathways.
  207. Moritz, Albrecht; Lee, Kimberly; Rush, John; Polakiewicz, Roberto, Reagents for the detection of protein phosphorylation in anaplastic large cell lymphoma signaling pathways.
  208. Polakiewicz, Roberto; Goss, Valerie; Moritz, Albrecht; Gu, Ting-Lei; Lee, Kimberly, Reagents for the detection of protein phosphorylation in leukemia signaling pathways.
  209. Reed,Jennifer Lynne; Dall'Acqua,William; Van Snick,Jacques; Renauld,Jean Christophe; Cormont,Francoise; Uyttenhove,Catherine, Recombinant anti-interleukin-9 antibodies.
  210. FitzGerald, David J.; Pastan, Ira; Mansfield, Elizabeth; Kreitman, Robert, Recombinant antibodies and immunoconjugates targeted to CD-22 bearing cells and tumors.
  211. Fitzgerald, David J.; Pastan, Ira; Mansfield, Elizabeth; Kreitman, Robert, Recombinant antibodies and immunoconjugates targeted to CD-22 bearing cells and tumors.
  212. Dryja,Thaddeus P.; Friend,Stephen; Yandell,David W., Retinoblastoma nucleic acids.
  213. Smith, Ernest S.; Croy, Leslie A.; Scrivens, Maria G. M., Selection of human TNFα specific antibodies.
  214. Oxvig, Claus; Mikkelsen, Jakob Hauge; Nielsen, Claus Gyrup, Selective exosite inhibition of PAPP-A activity against IGFBP-4.
  215. Smith David S. (London GB2), Specific binding assay conjugate with spaced-apart receptors.
  216. Sawayanagi Yoichi (Tokyo JPX), Stable antibody solution and method for preparing same.
  217. Griffiths,Gary L.; Hansen,Hans J.; Goldenberg,David M., Targeted combination immunotherapy.
  218. Griffiths, Gary L.; Hansen, Hans J.; Goldenberg, David M., Targeted combination immunotherapy of cancer and infectious diseases.
  219. Griffiths, Gary L.; Hansen, Hans J.; Goldenberg, David M., Targeted combination immunotherapy of cancer and infectious diseases.
  220. Griffiths,Gary L.; Hansen,Hans J.; Goldenberg,David M., Targeted combination immunotherapy of cancer and infectious diseases.
  221. Romet-Lemonne Jean Loup,FRX ; Fanger Michael W. ; Guyre Paul M. ; Gosselin Edmund J., Targeted immunostimulation with bispecific reagents.
  222. Tanamachi, Dawn M.; Brams, Peter; Black, Amelia, Transgenic animals expressing chimeric antibodies for use in preparing human antibodies.
  223. Tanamachi, Dawn M.; Brams, Peter; Black, Amelia, Transgenic animals expressing chimeric antibodies for use in preparing human antibodies.
  224. Finberg,Robert W., Transgenic mice expressing heterologous complement receptor type 1 (CR1) molecules on erythrocytes and uses therefor.
  225. Lonberg Nils ; Kay Robert M., Transgenic non-human animals capable of producing heterologous antibodies.
  226. Lonberg, Nils; Kay, Robert M., Transgenic non-human animals for producing chimeric antibodies.
  227. Lonberg, Nils; Kay, Robert M., Transgenic non-human animals for producing chimeric antibodies.
  228. Lonberg,Nils; Kay,Robert M., Transgenic non-human animals for producing chimeric antibodies.
  229. Yang, Haining; Carbone, Michele; Bianchi, Marco E., Treatment and prevention of cancer with HMGB1 antagonists.
  230. Yu, Guo Liang; Ni, Jian; Rosen, Craig A.; Zhang, Jun, Tumor necrosis factor-gamma.
  231. Yu, Guo-Liang; Ni, Jian; Rosen, Craig A.; Zhang, Jun, Tumor necrosis factor-gamma.
  232. Yu, Guo-Liang; Ni, Jian; Rosen, Craig A.; Zhang, Jun, Tumor necrosis factor-gamma.
  233. Hornbeck, Peter; Guo, Ailan; Gu, Ting-Lei; Rikova, Klarisa; Moritz, Albrecht; Farnsworth, Charles; Stokes, Matthew; Yu, Jian; Spek, Erik; Li, Yu; Possemato, Anthony; Cherry, Jessica; Goss, Valerie; Mitchell, Jeffrey; Rush, John; Michaud, Corinne, Tyrosine phosphorylation sites.
  234. Lucas, John; Briggs, Kristen, Use of adipsin/complement factor D in the treatment of metabolic related disorders.
  235. Ni, Jian; Rosen, Craig A.; Gentz, Reiner L., Use of an antibody that binds human tumor necrosis factor receptor-like 2.
  236. Pandey, Ravindra K.; Gryshuk, Amy; Goswami, Lalit; Potter, William; Oseroff, Allan, Water soluble tetrapyrollic photosensitizers for photodynamic therapy.
  237. Pandey,Ravindra K.; Gryshuk,Amy; Goswami,Lalit; Potter,William; Oseroff,Allan, Water soluble tetrapyrollic photosensitizers for photodynamic therapy.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로